```

[Federal Register Volume 89, Number 227 (Monday, November 25, 2024)]
[Notices]
[Pages 92947-92948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27485]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Advisory 
Allergy and Infectious Diseases Council.
    The meetings will be held as virtual meetings and will be open to 
the public as indicated below. Individuals who plan to view the virtual 
meetings and need special assistance or other reasonable accommodations 
to view the meetings should notify the Contact Person listed below in 
advance of the meetings. The meetings can be accessed from the NIH 
Videocast at the following link: https://videocast.nih.gov/.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: January 27, 2025.
    Open: 10:30 a.m. to 11:30 a.m.
    Agenda: Report of Institute Director.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Closed: 11:45 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Allergy, Immunology and Transplantation 
Subcommittee.
    Date: January 27, 2025.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Microbiology and Infectious Diseases Subcommittee.
    Date: January 27, 2025.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.
    Date: January 27, 2025.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious, 
Diseases National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice at least 10 days in advance of the meeting. The 
statement should include the

[[Page 92948]]

name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.niaid.nih.gov/about/advisory-council, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 19, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-27485 Filed 11-22-24; 8:45 am]
BILLING CODE 4140-01-P
```